UK Markets close in 1 hr 31 mins

Oak Street Health, Inc. (OSH)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
21.93+0.31 (+1.43%)
As of 09:58AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close21.62
Open21.74
Bid21.63 x 800
Ask21.70 x 800
Day's range21.55 - 22.32
52-week range13.29 - 35.61
Volume96,796
Avg. volume1,806,366
Market cap5.284B
Beta (5Y monthly)2.71
PE ratio (TTM)N/A
EPS (TTM)-1.62
Earnings date27 Feb 2023 - 03 Mar 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est35.39
  • Business Wire

    Oak Street Health Announces Participation at 34th Annual Piper Sandler Healthcare Conference

    CHICAGO, November 23, 2022--Oak Street Health, Inc. (NYSE: OSH, or the "Company"), a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, today announced that Mike Pykosz, Chief Executive Officer, and Tim Cook, Chief Financial Officer, will participate in the 34th Annual Piper Sandler Healthcare Conference, including a fireside chat presentation at 11:30 a.m. (ET) on Wednesday, November 30, 2022.

  • Business Wire

    Oak Street Health Celebrates Two Recognitions in Crain’s Chicago Business Awards

    CHICAGO, November 09, 2022--Oak Street Health (NYSE: OSH), a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, today announced its Chief Medical Officer, Value-Based Care Strategy, Dr. Ali Khan, has been named a 2022 40 Under 40 honoree by Crain’s Chicago Business. Additionally, Oak Street Health also celebrates the recognition of Dr. Michele Mitchell, executive medical director, in Crain’s Chicago Business’ Notable Blac

  • Zacks

    Oak Street Health, Inc. (OSH) Reports Q3 Loss, Tops Revenue Estimates

    Oak Street Health, Inc. (OSH) delivered earnings and revenue surprises of 11.11% and 1%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?